{
    "nctId": "NCT03011684",
    "briefTitle": "Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial",
    "officialTitle": "Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Infertility",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 144,
    "primaryOutcomeMeasure": "Mature Oocyte Yield",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* New breast cancer diagnosis\n* Has not yet begun chemotherapy\n* Desires to undergo ovarian stimulation and oocyte retrieval prior to cancer treatment\n* Age 18 years old or greater\n\nExclusion Criteria:\n\n* Chemotherapy has already commenced or been completed\n* History of recurrent breast cancer (with a prior history of chemotherapy)\n* Stage IV breast cancer diagnosis (metastases remote from the breast)\n* Patient's oncologist advises against the trial - in which case they can choose to receive stimulation with letrozole+gonadotropin\n* Does not plan to undergo ovarian stimulation and oocyte retrieval prior to diagnosis\n* Any significant concurrent disease, illness, or psychiatric disorder that would compromise patient safety or compliance, interfere with consent, study participation, follow-up, or interpretation of study results\n* Age less than 18 years old",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}